Avita Medical | 1811094D - Operating Expenses



Avita Medical reported AUD28.36M in Operating Expenses for its fiscal semester ending in December of 2024.


Operating Expenses Change Date
Adcock Ingram Holdings ZAR 4.23B 196.72M Dec/2024
Celltrion KRW 718.99B 24.68B Jun/2025
Clinuvel Pharmaceuticals AUD 20.71M 2.35M Jun/2024
Cochlear AUD 897.2M 19.8M Dec/2024
CSL USD 5.72B 173M Dec/2024
Cspc Pharmaceutical CNY 5.22B 248.9M Mar/2025
Dianthus Therapeutics USD 35.12M 1.88M Jun/2025
Divis Laboratories Ltd 17.93B 130M Jun/2025
Kangmei Pharma CNY 1.25B 35.75M Jun/2025
Knight Therapeutics CAD 89.06M 2.02M Sep/2024
Laboratorios Farma EUR 132.33M 179.02M Jun/2025
Malin Corporation EUR 1.1M 400K Dec/2024
Mayne Pharma AUD 103.54M 9.39M Jun/2024
Medical Developments International AUD 19.8M 9.46M Dec/2024
Nanosonics AUD 84.9M 42.29M Dec/2024
Neuren Pharmaceuticals AUD 17.41M 2.86M Dec/2024
Organigram Holdings CAD 72.9M 18.86M Jun/2025
Pacific Edge NZD 26.27M 12.77M Sep/2024
Paradigm Biopharmaceuticals AUD 6.36M 8.6M Dec/2024
Pharma Mar EUR 32.29M 9.66M Jun/2025
Polynovo AUD 27.51M 19.08M Jun/2024
PYC Therapeutics AUD 38.58M 20.29M Dec/2024
Qiagen NV USD 397.57M 39.27M Jun/2025
Ramsay Health Care AUD 8.35B 258.6M Dec/2024
ResMed USD 891.42M 26.57M Jun/2025
Sartorius EUR 722.5M 23.1M Jun/2025
Sino Biopharmaceutical CNY 11.66B 352.34M Dec/2024
Telix Pharmaceuticals AUD 191.9M 130.08M Dec/2024
Tilray USD 253.17M 16.55M Nov/2024
Zz Pientze Pharmaceu 1.68B 272.39M Jun/2025